Nathan’s Story: VCP Disease and the need for a Rare Disease Advisory Council in Georgia

Since I was a freshman at Georgia Tech, I have had a clock ticking in my head.  Since my mother presented symptoms of the VCP gene mutation, I had grown up knowing that a rare disease existed in my family and that there was a 50% chance that I might get it as an adult in my 30’s to 40’s. My mother and aunt are both deceased from the disease, and I have two uncles (four out of six siblings) that possess the VCP gene mutation that was passed down from their mother.  Symptoms include muscle wasting, Paget’s disease of bone, frontotemporal dementia, ALS and Parkinson’s.  A patient can get any combination of symptoms and the disease is fatal.  For ten years, my mother could not walk, feed herself, bathe herself or go to the bathroom by herself and my dad was her primary care partner.  I know what my future holds, and my advocacy work is for my three boys.

I jumped at every career opportunity to advance as quickly as possible.  Some might even say I was reckless.  I quit a six-figure job and moved my wife and two sons at the time to Boston to attend grad school at MIT as I knew I might not get another shot.  My oldest son lived in six states by the time he was nine and I did everything I could do to advance professionally in the event that I was “lucky” enough to have the gene mutation.

In my late 30’s, after feeling weakness in my muscles and receiving my positive gene mutation diagnosis from a researcher in California, I visited the Emory neuromuscular center to request a nuclear bone scan.  There are no treatments for my disease except for Paget’s disease of bone, if detected early enough.  During that first appointment, the doctor looked at me and said that he had never heard of my disease and that it might all be in my head.  My wife and I spent the next 45 minutes educating him about what to expect with a VCP gene mutation to not much success.  It wasn’t until I visited the Emory ALS Clinic that I found a doctor familiar with my genetic mutation.  I am his only patient with my genetic mutation. In rare diseases, access to specialty and timely medical care is crucial and can save lives and the unnecessary costs. Because there may be only a few experts in the world, many patients do not receive the care that they need.

After leading multiple businesses, I am now on full disability as we were “blessed” that I made some wise financial decisions to protect my family. I am still somewhat independent now, but my disease is progressive so I will continue to lose strength, energy, and the ability to walk. My wife and children are having to take a larger share of things l feel I should do, like mow the lawn, clean the gutters, and get things from the attic. I wish I could still do dad things like teach my boys to play basketball or take them camping. I am blessed with a wonderful family, but my rare disease is a burden to them. Rare disease affects everyone in the family. One in 10 people have a rare disease, 50% are pediatric diseases and only 5% of rare diseases have a cure. Rare disease affects many families in Georgia.

Others are not so “blessed” as I have been, and it is vital that we protect and advocate for those affected by rare disease.  My wife and I started a rare disease non-profit, Cure VCP Disease, in 2018, headquartered in Americus, Georgia, in order to help make life better for other rare disease families. We have funded research, facilitated scientific collaborations, and established a supportive patient community.

There are over 7,000 rare diseases and rare disease is complex.  I’ve learned how complex it is only because I am an affected patient.  HB 918, which advocates for the creation of a Rare Disease Advisory Council in Georgia will be one voice that can aid legislators, policy makers and the general Georgia population, in making prudent decisions to support and help rare disease patients and care partners in Georgia.  Finding a cure and treatment for rare disease is only half the battle. How will it be administered and most importantly, how will it be paid for?  Those are only a few of the important issues that the Rare Disease Advisory Council can help advise the people and representatives of Georgia.

October 28, 2026
New national report highlights Georgia’s growing bioscience workforce, research enterprise, and investment activity October 28— Georgia’s bioscience industry continues to expand its economic footprint, supporting 42,605 jobs across 4,281 business establishments statewide in 2025, according to a new report examining the economic impact of the U.S. bioscience industry. The U.S. Bioscience Economy: Advancing Innovation and Strengthening States and Regions, published by the Biotechnology Innovation Organization (BIO), the Council of State Bioscience Associations, and TEConomy Partners, provides a comprehensive assessment of the bioscience industry’s contributions to employment, wages, business growth, university research and development, and access to capital across all 50 states, Washington, D.C., and Puerto Rico. Georgia’s bioscience employment grew 7.6% between 2021 and 2025, slightly outpacing national growth. The state recorded employment gains across all five major bioscience industry subsectors, demonstrating the breadth of its life sciences economy. “Georgia’s bioscience industry is an important contributor to our state’s economic competitiveness, creating high-quality jobs and advancing research and innovation,” said Maria Thacker Goethe, President and CEO of Georgia Life Sciences. “These findings underscore the opportunity to build on Georgia’s strengths by strengthening connections among research institutions, industry, investors, and workforce partners to help more life sciences companies innovate and grow here.” Georgia’s Bioscience Industry: Key Findings The report highlights several indicators of Georgia’s bioscience industry strength: 42,605 jobs: Georgia’s bioscience industry employed more than 42,000 people in 2025, with employment growing 7.6% from 2021 to 2025. 4,281 business establishments: Bioscience companies and related businesses operate across the state, contributing to Georgia’s diverse economic base. $112,712 in average annual wages: Bioscience industry wages exceeded Georgia’s private-sector average by 52%, highlighting the sector’s contribution to high-value employment. $2.0 billion in university bioscience research: Georgia universities conducted $2.0 billion in bioscience-related research and development in fiscal year 2024. $789.5 million in NIH funding: Georgia institutions received $789.5 million in National Institutes of Health funding in fiscal year 2025. $1.5 billion in venture capital investment: Georgia bioscience companies attracted $1.5 billion in venture capital from 2021 through 2025. Georgia’s bioscience distribution subsector, the state’s largest, expanded employment by 10.3% during the period. Agricultural feedstock and industrial biosciences recorded the fastest percentage growth, reflecting the breadth of activity across the state’s bioscience economy. National Industry Impact Nationally, the U.S. bioscience industry generated $3.19 trillion in total economic output and directly employed 2.31 million Americans across more than 156,000 business establishments. The report examines the industry's economic footprint and the factors that support its continued growth, including research investment, workforce development, and access to capital. Building on Georgia’s Life Sciences Momentum The findings highlight Georgia’s substantial research enterprise, established industry base, and ability to attract investment. Continued growth will depend on strengthening the connections that help translate scientific discoveries into commercial opportunities, expand access to capital, develop a skilled workforce, and provide the infrastructure companies need to scale. Georgia Life Sciences works to advance the state’s life sciences ecosystem through policy and advocacy, workforce development, industry convening, and strategic collaboration. Its statewide roadmap, Pathways & Partnerships: A Roadmap for Georgia’s Life Sciences Sector, outlines a long-term vision for positioning Georgia as a leading scale-up manufacturing hub in the Southeast. “Georgia has significant assets across research, manufacturing, workforce, and logistics,” Goethe said. “By coordinating these strengths and addressing the gaps that can limit company growth, we can create more opportunities for innovation, investment, and long-term economic impact across the state.” Read the Report The full report, The U.S. Bioscience Economy: Advancing Innovation and Strengthening States and Regions, and Georgia’s state-specific profile are available from the Biotechnology Innovation Organization. Explore the national report and findings Download Georgia’s state profile (PDF)
October 22, 2026
Georgia Life Sciences connected 23 educators with hands-on STEM learning and industry experts at its Savannah workshop to strengthen the workforce pipeline.
October 22, 2026
Georgia Life Sciences Institute connects 23 chemistry teachers with industry professionals to bring real-world career opportunities into the classroom. The Georgia Life Sciences Institute (GLSI) recently organized an industry visit for 23 Forsyth County chemistry teachers to Bend Bioscience in Gainesville, Georgia, offering educators a firsthand look at the careers, skills, and opportunities available within the state's growing life sciences sector. During the visit, teachers engaged directly with Bend Bioscience employees, toured the facility, and explored how concepts taught in chemistry classrooms translate into real-world applications. Conversations focused on workforce needs, career pathways, and the combination of technical and professional skills that help employees succeed in the life sciences industry. A particular area of interest was Quality Assurance and Quality Control (QA/QC), functions essential to maintaining the quality, safety, and consistency of life sciences products. These discussions helped educators better understand the range of careers available to students, including opportunities beyond traditional research and laboratory roles. The experience also demonstrated the impact of connecting educators directly with industry. Several participating teachers shared that the visit inspired them to discuss life sciences career opportunities with their own children, illustrating how greater career awareness can extend beyond the classroom. Both the educators and Bend Bioscience team expressed interest in continued engagement, reinforcing the value of building stronger connections between Georgia's schools and life sciences employers. Connecting Education and Industry Through initiatives like this visit, GLSI works to bridge the gap between education and industry by giving teachers direct exposure to the companies, technologies, and careers shaping Georgia's life sciences ecosystem. By equipping educators with firsthand industry knowledge, GLSI helps bring greater career awareness and real-world relevance into classrooms across the state, introducing students to pathways they may not have previously considered. Georgia Life Sciences Institute extends its appreciation to Bend Bioscience for welcoming Forsyth County educators and investing time in the teachers who help prepare Georgia's future workforce. Together, these partnerships are helping build awareness of the diverse opportunities available in Georgia's life sciences industry and strengthen the state's future talent pipeline.
MORE POSTS